Fresenius Medical Care AG ADR (NYSE: FMS) has a price-to-earnings ratio that is above its average at 18.46x. The stock has a 36-month beta value of 0.91. Opinions on the stock are mixed, with 1 analysts rating it as a “buy,” 1 as “overweight,” 3 as “hold,” and 1 as “sell.”
The public float for FMS is 586.39M, and at present, short sellers hold a 0.15% of that float. On December 20, 2024, the average trading volume of FMS was 249.32K shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
FMS) stock’s latest price update
The stock of Fresenius Medical Care AG ADR (NYSE: FMS) has decreased by -2.43 when compared to last closing price of 23.04. Despite this, the company has experienced a -5.11% fall in its stock price over the last five trading sessions. zacks.com reported 2024-12-17 that Value investing is essentially about selecting stocks that are usually cheap but fundamentally sound. TSN, GM, FMS and DLX boast a low P/CF ratio.
FMS’s Market Performance
Fresenius Medical Care AG ADR (FMS) has seen a -5.11% fall in stock performance for the week, with a 1.72% gain in the past month and a 11.01% surge in the past quarter. The volatility ratio for the week is 2.11%, and the volatility levels for the past 30 days are at 1.43% for FMS. The simple moving average for the last 20 days is -2.95% for FMS stock, with a simple moving average of 10.02% for the last 200 days.
Analysts’ Opinion of FMS
Berenberg, on the other hand, stated in their research note that they expect to see FMS reach a price target of $25.60. The rating they have provided for FMS stocks is “Buy” according to the report published on November 06th, 2024.
FMS Trading at 3.55% from the 50-Day Moving Average
After a stumble in the market that brought FMS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -7.53% of loss for the given period.
Volatility was left at 1.43%, however, over the last 30 days, the volatility rate increased by 2.11%, as shares surge +3.17% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +11.95% upper at present.
During the last 5 trading sessions, FMS fell by -5.11%, which changed the moving average for the period of 200-days by +12.12% in comparison to the 20-day moving average, which settled at $23.16. In addition, Fresenius Medical Care AG ADR saw 7.92% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for FMS
Current profitability levels for the company are sitting at:
- 0.08 for the present operating margin
- 0.25 for the gross margin
The net margin for Fresenius Medical Care AG ADR stands at 0.03. The total capital return value is set at 0.06. Equity return is now at value 4.76, with 1.93 for asset returns.
Based on Fresenius Medical Care AG ADR (FMS), the company’s capital structure generated 0.35 points at debt to capital in total, while cash flow to debt ratio is standing at 0.31. The debt to equity ratio resting at 0.53. The interest coverage ratio of the stock is 3.95.
Currently, EBITDA for the company is 3.21 billion with net debt to EBITDA at 3.08. When we switch over and look at the enterprise to sales, we see a ratio of 1.17. The receivables turnover for the company is 5.87for trailing twelve months and the total asset turnover is 0.59. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.37.
Conclusion
To sum up, Fresenius Medical Care AG ADR (FMS) has seen a better performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
